0000950170-23-053819.txt : 20231017 0000950170-23-053819.hdr.sgml : 20231017 20231017175227 ACCESSION NUMBER: 0000950170-23-053819 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231013 FILED AS OF DATE: 20231017 DATE AS OF CHANGE: 20231017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morrow Phuong Khanh CENTRAL INDEX KEY: 0001928989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 231330506 MAIL ADDRESS: STREET 1: C/O CRISPR THERAPEUTICS STREET 2: 610 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 ownership.xml 4 X0508 4 2023-10-13 0001674416 CRISPR Therapeutics AG CRSP 0001928989 Morrow Phuong Khanh C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET BOSTON MA 02127 true Chief Medical Officer false Stock Option (Right to Buy) 44.31 2023-10-13 4 A false 16667 0 A 2033-10-13 Common Shares 16667 16667 D This option was granted on October 13, 2023 with respect to 16,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023. /s/ Elizabeth Ryland Waldinger, attorney-in-fact 2023-10-17